Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Product Type (IGG, IGA, IGM, IGE, and IGD), and by Mode of Delivery (Intravenous and Subcutaneous): Global Opportunity Analysis and Industry Forecast, 2020-2030

Immunoglobulin Market

Industry:  Life Sciences & Healthcare | Publish Date: Sep 2020 | No of Pages:  679 | No. Tables:  276 | No. Figures:  246

Market Definition:

The Global Immunoglobulin Market size was valued at USD 11.23 billion in 2019 and is predicted to reach USD 20.23 billion by 2030 with a CAGR of 5.4% from 2020-2030.

Immunoglobulins are glycoproteins produced by plasma cells and other lymphocytes. Immunoglobulin protects the body from diseases by acting as an antibody to support the immune system against disease causing agents such as virus, bacteria and others. These are obtained from blood through fractionation process and then purified for different therapeutic and non-therapeutic applications. Immunoglobulins are classified into different classes and isotopes, biological features, and target structures among others. These antibodies are administered to the body trough intravenous and subcutaneous modes of drug delivery.

Market Dynamics and Trends

Key factors fueling the growth of the immunoglobulin market during the forecast period are increase in geriatric population along with rise in the number of hemophilic patients. Additionally, advanced technology coupled with enhanced purification processes have paved the way for improved immunoglobulin production. Other factors such as prevalence of chronic inflammatory diseases in conjunction with increasing awareness and reduced side effects are anticipated to drive market growth during the forecast period.

However, stringent government regulations along with risk of side effects are factors expected to hamper the immunoglobulin market growth. On the other hand, innovation, research and development are anticipated to create numerous opportunities in the immunoglobulin market during the forecast period.

Market Segmentations and Scope of the Study:

The immunoglobulin market is segmented on the basis of product, application, mode of delivery and region. On the basis of product, the market is segmented into IGG, IGA, IGM, IGE and IGD. On the basis of application, the market is segmented into Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura (ITP), Inflammatory Myopathies, Specific Antibody Deficiency, Guillain Barre Syndrome, and Others. On the basis of mode of delivery, the market is segmented into intravenous and subcutaneous. Intravenous is sub segmented into 5% concentration, 10% concentration and others. Subcutaneous is sub segmented into 16.5% concentration, 20% concentration and others. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.

Geographical Analysis

North America currently dominates the market and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the factors such as presence of developed economies along with the rising prevalence of hemophilia. Also, other factors such as developed healthcare facilities, improved infrastructure and enhancement in technologies related to purification are anticipated to further propel the growth of the immunoglobulin market.

However, Asia Pacific is predicted to show rapid and consistent growth in market share within the forecast period owing to the increase in accessibility of healthcare facilities coupled with rising inflammatory diseases. Also, rising geriatric population in this region is expected to add revenue to the immunoglobulin market during the forecast period.

Competitive Landscape

Lucrative growth opportunities make the immunoglobulin market extremely competitive. Some of the major players in the market are CSL Ltd., Baxter international Inc., Octapharma AG, Grifols S.A, LFB SA, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Shire (Baxalta), and Bayer Healthcare among others. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by market players to maintain market dominance.

For instance, in January 2019, Kedrion Biopharma announced that the U.S. Food and Drug Administration has accepted their Investigational New Drug (IND) application for a clinical study aimed at assessing efficacy and safety of a 10% intravenous immunoglobulin in the treatment of adult patients with primary immunodeficiency diseases (PID). This approval allows Kedrion to initiate clinical trial in the United States in coming months.

KEY BENEFITS

  • The immunoglobulin report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on

  • The study comprises a deep dive analysis of the immunoglobulin market trend including the current and future trends for depicting the prevalent investment pockets in the market

  • The information related to key drivers, restraints and opportunities and their impact on the immunoglobulin market is provided in the report.

  • The market share of the players in the global immunoglobulin market along with their competitive analysis.

  • Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Product

  • IGG

  • IGA

  • IGM

  • IGE

  • IGD

By Application

  • Hypogammaglobulinemia

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Immunodeficiency Disease

  • Myasthenia Gravis

  • Multifocal Motor Neuropathy

  • Idiopathic Thrombocytopenic Purpura (ITP)

  • Inflammatory Myopathies

  • Specific Antibody Deficiency

  • Guillain Barré Syndrome

  • Others

By Mode of Delivery

  • Intravenous

    • 5% Concentration

    • 10% Concentration

    • Others

  • Subcutaneous

    • 16.5% Concentration

    • 20% Concentration

    • Others

By Geography

  • North America

    • U.S

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Austria

    • Russia

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India 

    • Australia

    • Rest of Asia-Pacific

  • RoW

    • Brazil

    • Saudi Arabia

    • Argentina

    • Remaining Countries

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2019–2030

Base Year Considered

2019

Forecast Period

2020–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Product Type (IGG, IGA, IGM, IGE, and IGD), and by Mode of Delivery (Intravenous and Subcutaneous)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Austria, Russia, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Rest of the World (Brazil, Saudi Arabia, Argentina, Remaining Countries)

Companies Profiled

CSL Ltd., Baxter international Inc., Octapharma AG, Grifols S.A, LFB SA, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Shire (Baxalta), and Bayer Healthcare.

column chart pie chart

1.    INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Research Methodology

1.2.1             Secondary Research

1.2.2             Data Analysis Framework

1.2.3             Market size estimation

1.2.4             Forecasting

1.2.5             Primary Research and Data Validation

2.    MARKET SNAPSHOT, 2019-2030 MILLION USD/VOLUME

2.1.           MARKET SNAPSHOT

3.    PORTER’S FIVE FORCE MODEL ANALYSIS

4.    MARKET DYNAMICS

4.1.           GROWTH DRIVERS

4.1.1             DRIVER 1

4.1.2             DRIVER 2

4.1.3             DRIVER 3

4.1.4             DRIVER 4

4.2.           CHALLENGES

4.2.1             CHALLENGE 1

4.2.2             CHALLENGE 2

4.3.           OPPORTUNITIES

4.3.1             OPPORTUNITY 1

4.3.2             OPPORTUNITY 2

5.    Global  Immunoglobulin Market, By Application

5.1.           Overview

5.2.           Hypogammaglobulinemia

5.2.1             Hypogammaglobulinemia Market, By Region

5.2.1.1        North America Hypogammaglobulinemia Market, By Country

5.2.1.2        Europe Hypogammaglobulinemia Market, By Country

5.2.1.3        Asia-Pacific Hypogammaglobulinemia Market, By Country

5.2.1.4        Rest of World Hypogammaglobulinemia Market, By Country

5.3.           Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.3.1             Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Region

5.3.1.1        North America Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Country

5.3.1.2        Europe Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Country

5.3.1.3        Asia-Pacific Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Country

5.3.1.4        Rest of World Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market, By Country

5.4.           Primary Immunodeficiency Diseases

5.4.1             Primary Immunodeficiency Diseases Market, By Region

5.4.1.1        North America Primary Immunodeficiency Diseases Market, By Country

5.4.1.2        Europe Primary Immunodeficiency Diseases Market, By Country

5.4.1.3        Asia-Pacific Primary Immunodeficiency Diseases Market, By Country

5.4.1.4        Rest of World Primary Immunodeficiency Diseases Market, By Country

5.5.           Myasthenia Gravis

5.5.1             Myasthenia Gravis Market, By Region

5.5.1.1        North America Myasthenia Gravis Market, By Country

5.5.1.2        Europe Myasthenia Gravis Market, By Country

5.5.1.3        Asia-Pacific Myasthenia Gravis Market, By Country

5.5.1.4        Rest of World Myasthenia Gravis Market, By Country

5.6.           Multifocal Motor Neuropathy

5.6.1             Multifocal Motor Neuropathy Market, By Region

5.6.1.1        North America Multifocal Motor Neuropathy Market, By Country

5.6.1.2        Europe Multifocal Motor Neuropathy Market, By Country

5.6.1.3        Asia-Pacific Multifocal Motor Neuropathy Market, By Country

5.6.1.4        Rest of World Multifocal Motor Neuropathy Market, By Country

5.7.           Idiopathic Thrombocytopenic Purpura (ITP)

5.7.1             Idiopathic Thrombocytopenic Purpura (ITP) Market, By Region

5.7.1.1        North America Idiopathic Thrombocytopenic Purpura (ITP) Market, By Country

5.7.1.2        Europe Idiopathic Thrombocytopenic Purpura (ITP) Market, By Country

5.7.1.3        Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Market, By Country

5.7.1.4        Rest of World Idiopathic Thrombocytopenic Purpura (ITP) Market, By Country

5.8.           Inflammatory Myopathies

5.8.1             Inflammatory Myopathies Market, By Region

5.8.1.1        North America Inflammatory Myopathies Market, By Country

5.8.1.2        Europe Inflammatory Myopathies Market, By Country

5.8.1.3        Asia-Pacific Inflammatory Myopathies Market, By Country

5.8.1.4        Rest of World Inflammatory Myopathies Market, By Country

5.9.           Specific Antibody Deficiency

5.9.1             Specific Antibody Deficiency Market, By Region

5.9.1.1        North America Specific Antibody Deficiency Market, By Country

5.9.1.2        Europe Specific Antibody Deficiency Market, By Country

5.9.1.3        Asia-Pacific Specific Antibody Deficiency Market, By Country

5.9.1.4        Rest of World Specific Antibody Deficiency Market, By Country

5.10.         Guillain-Barre Syndrome

5.10.1           Guillain-Barre Syndrome Market, By Region

5.10.1.1      North America Guillain-Barre Syndrome Market, By Country

5.10.1.2      Europe Guillain-Barre Syndrome Market, By Country

5.10.1.3      Asia-Pacific Guillain-Barre Syndrome Market, By Country

5.10.1.4      Rest of World Guillain-Barre Syndrome Market, By Country

5.11.         Other Application

5.11.1           Other Application Market, By Region

5.11.1.1      North America Other Application Market, By Country

5.11.1.2      Europe Other Application Market, By Country

5.11.1.3      Asia-Pacific Other Application Market, By Country

5.11.1.4      Rest of World Other Application Market, By Country

6.    Global  Immunoglobulin Market, By Product

6.1.           Overview

6.2.           IGG

6.2.1             IGG Market, By Region

6.2.1.1        North America IGG Market, By Country

6.2.1.2        Europe IGG Market, By Country

6.2.1.3        Asia-Pacific IGG Market, By Country

6.2.1.4        Rest of World IGG Market, By Country

6.3.           IGA

6.3.1             IGA Market, By Region

6.3.1.1        North America IGA Market, By Country

6.3.1.2        Europe IGA Market, By Country

6.3.1.3        Asia-Pacific IGA Market, By Country

6.3.1.4        Rest of World IGA Market, By Country

6.4.           IGM

6.4.1             IGM Market, By Region

6.4.1.1        North America IGM Market, By Country

6.4.1.2        Europe IGM Market, By Country

6.4.1.3        Asia-Pacific IGM Market, By Country

6.4.1.4        Rest of World IGM Market, By Country

6.5.           IGE

6.5.1             IGE Market, By Region

6.5.1.1        North America IGE Market, By Country

6.5.1.2        Europe IGE Market, By Country

6.5.1.3        Asia-Pacific IGE Market, By Country

6.5.1.4        Rest of World IGE Market, By Country

6.6.           IGD

6.6.1             IGD Market, By Region

6.6.1.1        North America IGD Market, By Country

6.6.1.2        Europe IGD Market, By Country

6.6.1.3        Asia-Pacific IGD Market, By Country

6.6.1.4        Rest of World IGD Market, By Country

7.    Global  Immunoglobulin Market, By Mode of Delivery

7.1.           Overview

7.2.           Intravenous Mode of Delivery

7.2.1             Global Intravenous Mode of Delivery Market, By Mode of Delivery

7.2.1.1% concentration Market, By Region

7.2.1.1.1        North America 5% concentration Market, By Country

7.2.1.1.2        Europe 5% concentration Market, By Country

7.2.1.1.3        Asia-Pacific 5% concentration Market, By Country

7.2.1.1.4        Rest of World 5% concentration Market, By Country

7.2.1.2% Concentration Market, By Region

7.2.1.2.1        North America 10% Concentration Market, By Country

7.2.1.2.2        Europe 10% Concentration Market, By Country

7.2.1.2.3        Asia-Pacific 10% Concentration Market, By Country

7.2.1.2.4        Rest of World 10% Concentration Market, By Country

7.2.1.3        Other Concentrations Market, By Region

7.2.1.3.1        North America Other Concentrations Market, By Country

7.2.1.3.2        Europe Other Concentrations Market, By Country

7.2.1.3.3        Asia-Pacific Other Concentrations Market, By Country

7.2.1.3.4        Rest of World Other Concentrations Market, By Country

7.2.2             Intravenous Mode of Delivery Market, By Region

7.2.2.1        North America Intravenous Mode of Delivery Market, By Country

7.2.2.2        Europe Intravenous Mode of Delivery Market, By Country

7.2.2.3        Asia-Pacific Intravenous Mode of Delivery Market, By Country

7.2.2.4        Rest of World Intravenous Mode of Delivery Market, By Country

7.3.           Subcutaneous Mode of Delivery

7.3.1             Global Subcutaneous Mode of Delivery Market, By Mode of Delivery

7.3.1.1.5% Concentration Market, By Region

7.3.1.1.1        North America 16.5% Concentration Market, By Country

7.3.1.1.2        Europe 16.5% Concentration Market, By Country

7.3.1.1.3        Asia-Pacific 16.5% Concentration Market, By Country

7.3.1.1.4        Rest of World 16.5% Concentration Market, By Country

7.3.1.2% Concentration Market, By Region

7.3.1.2.1        North America 20% Concentration Market, By Country

7.3.1.2.2        Europe 20% Concentration Market, By Country

7.3.1.2.3        Asia-Pacific 20% Concentration Market, By Country

7.3.1.2.4        Rest of World 20% Concentration Market, By Country

7.3.1.3        Other Market, By Region

7.3.1.3.1        North America Other Market, By Country

7.3.1.3.2        Europe Other Market, By Country

7.3.1.3.3        Asia-Pacific Other Market, By Country

7.3.1.3.4        Rest of World Other Market, By Country

7.3.2             Subcutaneous Mode of Delivery Market, By Region

7.3.2.1        North America Subcutaneous Mode of Delivery Market, By Country

7.3.2.2        Europe Subcutaneous Mode of Delivery Market, By Country

7.3.2.3        Asia-Pacific Subcutaneous Mode of Delivery Market, By Country

7.3.2.4        Rest of World Subcutaneous Mode of Delivery Market, By Country

8.    Global  Immunoglobulin Market, By Region

8.1.           Overview

8.2.           North America

8.2.1             North America Immunoglobulin Market, By Application

8.2.2             North America Immunoglobulin Market, By Product

8.2.3             North America Immunoglobulin Market, By Mode of Delivery

8.2.3.1        North America  Intravenous Mode of Delivery Market, By Mode of Delivery

8.2.3.2        North America  Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.2.4             North America Immunoglobulin, Market By Country

8.2.4.1        U.S.

8.2.4.1.1        U.S. Immunoglobulin Market, By Application

8.2.4.1.2        U.S. Immunoglobulin Market, By Product

8.2.4.1.3        U.S. Immunoglobulin Market, By Mode of Delivery

8.2.4.1.3.1. U.S. Intravenous Mode of Delivery Market, By Mode of Delivery

8.2.4.1.3.2. U.S. Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.2.4.2        Canada

8.2.4.2.1        Canada Immunoglobulin Market, By Application

8.2.4.2.2        Canada Immunoglobulin Market, By Product

8.2.4.2.3        Canada Immunoglobulin Market, By Mode of Delivery

8.2.4.2.3.1. Canada Intravenous Mode of Delivery Market, By Mode of Delivery

8.2.4.2.3.2. Canada Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.2.4.3        Mexico

8.2.4.3.1        Mexico Immunoglobulin Market, By Application

8.2.4.3.2        Mexico Immunoglobulin Market, By Product

8.2.4.3.3        Mexico Immunoglobulin Market, By Mode of Delivery

8.2.4.3.3.1. Mexico Intravenous Mode of Delivery Market, By Mode of Delivery

8.2.4.3.3.2. Mexico Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.           Europe

8.3.1             Europe Immunoglobulin Market, By Application

8.3.2             Europe Immunoglobulin Market, By Product

8.3.3             Europe Immunoglobulin Market, By Mode of Delivery

8.3.3.1        Europe  Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.3.2        Europe  Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4             Europe Immunoglobulin, Market By Country

8.3.4.1        Germany

8.3.4.1.1        Germany Immunoglobulin Market, By Application

8.3.4.1.2        Germany Immunoglobulin Market, By Product

8.3.4.1.3        Germany Immunoglobulin Market, By Mode of Delivery

8.3.4.1.3.1. Germany Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.1.3.2. Germany Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4.2        UK

8.3.4.2.1        UK Immunoglobulin Market, By Application

8.3.4.2.2        UK Immunoglobulin Market, By Product

8.3.4.2.3        UK Immunoglobulin Market, By Mode of Delivery

8.3.4.2.3.1. UK Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.2.3.2. UK Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4.3        France

8.3.4.3.1        France Immunoglobulin Market, By Application

8.3.4.3.2        France Immunoglobulin Market, By Product

8.3.4.3.3        France Immunoglobulin Market, By Mode of Delivery

8.3.4.3.3.1. France Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.3.3.2. France Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4.4        Italy

8.3.4.4.1        Italy Immunoglobulin Market, By Application

8.3.4.4.2        Italy Immunoglobulin Market, By Product

8.3.4.4.3        Italy Immunoglobulin Market, By Mode of Delivery

8.3.4.4.3.1. Italy Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.4.3.2. Italy Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4.5        Austria

8.3.4.5.1        Austria Immunoglobulin Market, By Application

8.3.4.5.2        Austria Immunoglobulin Market, By Product

8.3.4.5.3        Austria Immunoglobulin Market, By Mode of Delivery

8.3.4.5.3.1. Austria Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.5.3.2. Austria Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4.6        Russia

8.3.4.6.1        Russia Immunoglobulin Market, By Application

8.3.4.6.2        Russia Immunoglobulin Market, By Product

8.3.4.6.3        Russia Immunoglobulin Market, By Mode of Delivery

8.3.4.6.3.1. Russia Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.6.3.2. Russia Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.3.4.7        Rest of Europe

8.3.4.7.1        Rest of Europe Immunoglobulin Market, By Application

8.3.4.7.2        Rest of Europe Immunoglobulin Market, By Product

8.3.4.7.3        Rest of Europe Immunoglobulin Market, By Mode of Delivery

8.3.4.7.3.1. Rest of Europe Intravenous Mode of Delivery Market, By Mode of Delivery

8.3.4.7.3.2. Rest of Europe Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.4.           Asia-Pacific

8.4.1             Asia-Pacific Immunoglobulin Market, By Application

8.4.2             Asia-Pacific Immunoglobulin Market, By Product

8.4.3             Asia-Pacific Immunoglobulin Market, By Mode of Delivery

8.4.3.1        Asia-Pacific  Intravenous Mode of Delivery Market, By Mode of Delivery

8.4.3.2        Asia-Pacific  Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.4.4             Asia-Pacific Immunoglobulin, Market By Country

8.4.4.1        China

8.4.4.1.1        China Immunoglobulin Market, By Application

8.4.4.1.2        China Immunoglobulin Market, By Product

8.4.4.1.3        China Immunoglobulin Market, By Mode of Delivery

8.4.4.1.3.1. China Intravenous Mode of Delivery Market, By Mode of Delivery

8.4.4.1.3.2. China Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.4.4.2        India

8.4.4.2.1        India Immunoglobulin Market, By Application

8.4.4.2.2        India Immunoglobulin Market, By Product

8.4.4.2.3        India Immunoglobulin Market, By Mode of Delivery

8.4.4.2.3.1. India Intravenous Mode of Delivery Market, By Mode of Delivery

8.4.4.2.3.2. India Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.4.4.3        Japan

8.4.4.3.1        Japan Immunoglobulin Market, By Application

8.4.4.3.2        Japan Immunoglobulin Market, By Product

8.4.4.3.3        Japan Immunoglobulin Market, By Mode of Delivery

8.4.4.3.3.1. Japan Intravenous Mode of Delivery Market, By Mode of Delivery

8.4.4.3.3.2. Japan Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.4.4.4        Australia

8.4.4.4.1        Australia Immunoglobulin Market, By Application

8.4.4.4.2        Australia Immunoglobulin Market, By Product

8.4.4.4.3        Australia Immunoglobulin Market, By Mode of Delivery

8.4.4.4.3.1. Australia Intravenous Mode of Delivery Market, By Mode of Delivery

8.4.4.4.3.2. Australia Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.4.4.5        Rest of Asia-Pacific

8.4.4.5.1        Rest of Asia-Pacific Immunoglobulin Market, By Application

8.4.4.5.2        Rest of Asia-Pacific Immunoglobulin Market, By Product

8.4.4.5.3        Rest of Asia-Pacific Immunoglobulin Market, By Mode of Delivery

8.4.4.5.3.1. Rest of Asia-Pacific Intravenous Mode of Delivery Market, By Mode of Delivery

8.4.4.5.3.2. Rest of Asia-Pacific Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.5.           Rest of World

8.5.1             Rest of World Immunoglobulin Market, By Application

8.5.2             Rest of World Immunoglobulin Market, By Product

8.5.3             Rest of World Immunoglobulin Market, By Mode of Delivery

8.5.3.1        Rest of World  Intravenous Mode of Delivery Market, By Mode of Delivery

8.5.3.2        Rest of World  Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.5.4             Rest of World Immunoglobulin, Market By Country

8.5.4.1        Brazil

8.5.4.1.1        Brazil Immunoglobulin Market, By Application

8.5.4.1.2        Brazil Immunoglobulin Market, By Product

8.5.4.1.3        Brazil Immunoglobulin Market, By Mode of Delivery

8.5.4.1.3.1. Brazil Intravenous Mode of Delivery Market, By Mode of Delivery

8.5.4.1.3.2. Brazil Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.5.4.2        Saudi Arabia

8.5.4.2.1        Saudi Arabia Immunoglobulin Market, By Application

8.5.4.2.2        Saudi Arabia Immunoglobulin Market, By Product

8.5.4.2.3        Saudi Arabia Immunoglobulin Market, By Mode of Delivery

8.5.4.2.3.1. Saudi Arabia Intravenous Mode of Delivery Market, By Mode of Delivery

8.5.4.2.3.2. Saudi Arabia Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.5.4.3        Argentina

8.5.4.3.1        Argentina Immunoglobulin Market, By Application

8.5.4.3.2        Argentina Immunoglobulin Market, By Product

8.5.4.3.3        Argentina Immunoglobulin Market, By Mode of Delivery

8.5.4.3.3.1. Argentina Intravenous Mode of Delivery Market, By Mode of Delivery

8.5.4.3.3.2. Argentina Subcutaneous Mode of Delivery Market, By Mode of Delivery

8.5.4.4        Remaining Countries

8.5.4.4.1        Remaining Countries Immunoglobulin Market, By Application

8.5.4.4.2        Remaining Countries Immunoglobulin Market, By Product

8.5.4.4.3        Remaining Countries Immunoglobulin Market, By Mode of Delivery

8.5.4.4.3.1. Remaining Countries Intravenous Mode of Delivery Market, By Mode of Delivery

8.5.4.4.3.2. Remaining Countries Subcutaneous Mode of Delivery Market, By Mode of Delivery

9.    COMPANY PROFILES

9.1.           BAXTER INTERNATIONAL INC.

9.1.1             COMPANY OVERVIEW

9.1.2             COMPANY SNAPSHOT

9.1.3             OPERATING BUSINESS SEGMENTS

9.1.4             PRODUCT PORTFOLIO

9.1.5             BUSINESS PERFORMANCE

9.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.2.           BAYER AG

9.2.1             COMPANY OVERVIEW

9.2.2             COMPANY SNAPSHOT

9.2.3             OPERATING BUSINESS SEGMENTS

9.2.4             PRODUCT PORTFOLIO

9.2.5             BUSINESS PERFORMANCE

9.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.3.           BIOTEST AG

9.3.1             COMPANY OVERVIEW

9.3.2             COMPANY SNAPSHOT

9.3.3             OPERATING BUSINESS SEGMENTS

9.3.4             PRODUCT PORTFOLIO

9.3.5             BUSINESS PERFORMANCE

9.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.4.           CHINA BIOLOGIC PRODUCTS, INC.

9.4.1             COMPANY OVERVIEW

9.4.2             COMPANY SNAPSHOT

9.4.3             OPERATING BUSINESS SEGMENTS

9.4.4             PRODUCT PORTFOLIO

9.4.5             BUSINESS PERFORMANCE

9.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.5.           CSL LIMITED

9.5.1             COMPANY OVERVIEW

9.5.2             COMPANY SNAPSHOT

9.5.3             OPERATING BUSINESS SEGMENTS

9.5.4             PRODUCT PORTFOLIO

9.5.5             BUSINESS PERFORMANCE

9.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.6.           GRIFOLS S.A.

9.6.1             COMPANY OVERVIEW

9.6.2             COMPANY SNAPSHOT

9.6.3             OPERATING BUSINESS SEGMENTS

9.6.4             PRODUCT PORTFOLIO

9.6.5             BUSINESS PERFORMANCE

9.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.7.           KEDRION BIOPHARMA INC.

9.7.1             COMPANY OVERVIEW

9.7.2             COMPANY SNAPSHOT

9.7.3             OPERATING BUSINESS SEGMENTS

9.7.4             PRODUCT PORTFOLIO

9.7.5             BUSINESS PERFORMANCE

9.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.8.           LFB SA

9.8.1             COMPANY OVERVIEW

9.8.2             COMPANY SNAPSHOT

9.8.3             OPERATING BUSINESS SEGMENTS

9.8.4             PRODUCT PORTFOLIO

9.8.5             BUSINESS PERFORMANCE

9.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.9.           OCTAPHARMA AG

9.9.1             COMPANY OVERVIEW

9.9.2             COMPANY SNAPSHOT

9.9.3             OPERATING BUSINESS SEGMENTS

9.9.4             PRODUCT PORTFOLIO

9.9.5             BUSINESS PERFORMANCE

9.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.10.         SHIRE PLC.

9.10.1           COMPANY OVERVIEW

9.10.2           COMPANY SNAPSHOT

9.10.3           OPERATING BUSINESS SEGMENTS

9.10.4           PRODUCT PORTFOLIO

9.10.5           BUSINESS PERFORMANCE

9.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1.         Global  Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 2.         Hypogammaglobulinemia Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 3.         North America Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 4.         Europe Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 5.         Asia-Pacific Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 6.         Rest of World Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 7.         Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 8.         North America Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 9.         Europe Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 10.       Asia-Pacific Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 11.       Rest of World Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 12.       Primary Immunodeficiency Diseases Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 13.       North America Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 14.       Europe Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 15.       Asia-Pacific Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 16.       Rest of World Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 17.       Myasthenia Gravis Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 18.       North America Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 19.       Europe Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 20.       Asia-Pacific Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 21.       Rest of World Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 22.       Multifocal Motor Neuropathy Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 23.       North America Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 24.       Europe Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 25.       Asia-Pacific Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 26.       Rest of World Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 27.       Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 28.       North America Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 29.       Europe Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 30.       Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 31.       Rest of World Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 32.       Inflammatory Myopathies Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 33.       North America Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 34.       Europe Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 35.       Asia-Pacific Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 36.       Rest of World Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 37.       Specific Antibody Deficiency Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 38.       North America Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 39.       Europe Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 40.       Asia-Pacific Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 41.       Rest of World Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 42.       Guillain-Barre Syndrome Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 43.       North America Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 44.       Europe Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 45.       Asia-Pacific Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 46.       Rest of World Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 47.       Other Application Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 48.       North America Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 49.       Europe Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 50.       Asia-Pacific Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 51.       Rest of World Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 52.       Global  Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 53.       IGG Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 54.       North America IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 55.       Europe IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 56.       Asia-Pacific IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 57.       Rest of World IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 58.       IGA Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 59.       North America IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 60.       Europe IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 61.       Asia-Pacific IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 62.       Rest of World IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 63.       IGM Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 64.       North America IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 65.       Europe IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 66.       Asia-Pacific IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 67.       Rest of World IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 68.       IGE Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 69.       North America IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 70.       Europe IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 71.       Asia-Pacific IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 72.       Rest of World IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 73.       IGD Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 74.       North America IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 75.       Europe IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 76.       Asia-Pacific IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 77.       Rest of World IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 78.       Global  Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 79.       Global Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 80.       5% concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 81.       North America 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 82.       Europe 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 83.       Asia-Pacific 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 84.       Rest of World 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 85.       10% Concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 86.       North America 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 87.       Europe 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 88.       Asia-Pacific 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 89.       Rest of World 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 90.       Other Concentrations Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 91.       North America Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 92.       Europe Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 93.       Asia-Pacific Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 94.       Rest of World Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 95.       Intravenous Mode of Delivery Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 96.       North America Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 97.       Europe Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 98.       Asia-Pacific Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 99.       Rest of World Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 100.    Global Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 101.    16.5% Concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 102.    North America 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 103.    Europe 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 104.    Asia-Pacific 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 105.    Rest of World 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 106.    20% Concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 107.    North America 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 108.    Europe 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 109.    Asia-Pacific 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 110.    Rest of World 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 111.    Other Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 112.    North America Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 113.    Europe Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 114.    Asia-Pacific Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 115.    Rest of World Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 116.    Subcutaneous Mode of Delivery Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 117.    North America Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 118.    Europe Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 119.    Asia-Pacific Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 120.    Rest of World Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 121.    Global  Immunoglobulin Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 122.    North America Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 123.    North America Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 124.    North America Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 125.    North America  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 126.    North America  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 127.    U.S. Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 128.    U.S. Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 129.    U.S. Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 130.    U.S. Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 131.    U.S. Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 132.    Canada Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 133.    Canada Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 134.    Canada Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 135.    Canada Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 136.    Canada Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 137.    Mexico Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 138.    Mexico Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 139.    Mexico Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 140.    Mexico Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 141.    Mexico Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 142.    Europe Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 143.    Europe Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 144.    Europe Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 145.    Europe  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 146.    Europe  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 147.    Germany Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 148.    Germany Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 149.    Germany Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 150.    Germany Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 151.    Germany Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 152.    UK Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 153.    UK Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 154.    UK Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 155.    UK Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 156.    UK Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 157.    France Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 158.    France Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 159.    France Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 160.    France Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 161.    France Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 162.    Italy Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 163.    Italy Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 164.    Italy Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 165.    Italy Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 166.    Italy Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 167.    Austria Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 168.    Austria Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 169.    Austria Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 170.    Austria Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 171.    Austria Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 172.    Russia Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 173.    Russia Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 174.    Russia Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 175.    Russia Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 176.    Russia Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 177.    Rest of Europe Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 178.    Rest of Europe Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 179.    Rest of Europe Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 180.    Rest of Europe Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 181.    Rest of Europe Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 182.    Asia-Pacific Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 183.    Asia-Pacific Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 184.    Asia-Pacific Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 185.    Asia-Pacific  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 186.    Asia-Pacific  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 187.    China Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 188.    China Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 189.    China Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 190.    China Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 191.    China Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 192.    India Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 193.    India Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 194.    India Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 195.    India Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 196.    India Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 197.    Japan Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 198.    Japan Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 199.    Japan Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 200.    Japan Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 201.    Japan Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 202.    Australia Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 203.    Australia Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 204.    Australia Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 205.    Australia Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 206.    Australia Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 207.    Rest of Asia-Pacific Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 208.    Rest of Asia-Pacific Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 209.    Rest of Asia-Pacific Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 210.    Rest of Asia-Pacific Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 211.    Rest of Asia-Pacific Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 212.    Rest of World Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 213.    Rest of World Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 214.    Rest of World Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 215.    Rest of World  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 216.    Rest of World  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 217.    Brazil Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 218.    Brazil Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 219.    Brazil Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 220.    Brazil Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 221.    Brazil Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 222.    Saudi Arabia Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 223.    Saudi Arabia Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 224.    Saudi Arabia Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 225.    Saudi Arabia Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 226.    Saudi Arabia Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 227.    Argentina Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 228.    Argentina Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 229.    Argentina Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 230.    Argentina Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 231.    Argentina Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 232.    Remaining Countries Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

TABLE 233.    Remaining Countries Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

TABLE 234.    Remaining Countries Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 235.    Remaining Countries Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 236.    Remaining Countries Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

TABLE 237.    BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 238.    BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS

TABLE 239.    BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 240.    BAXTER INTERNATIONAL INC.: KEY STRATERGY

TABLE 241.    BAYER AG: COMPANY SNAPSHOT

TABLE 242.    BAYER AG: OPERATING SEGMENTS

TABLE 243.    BAYER AG: PRODUCT PORTFOLIO

TABLE 244.    BAYER AG: KEY STRATERGY

TABLE 245.    BIOTEST AG: COMPANY SNAPSHOT

TABLE 246.    BIOTEST AG: OPERATING SEGMENTS

TABLE 247.    BIOTEST AG: PRODUCT PORTFOLIO

TABLE 248.    BIOTEST AG: KEY STRATERGY

TABLE 249.    CHINA BIOLOGIC PRODUCTS, INC.: COMPANY SNAPSHOT

TABLE 250.    CHINA BIOLOGIC PRODUCTS, INC.: OPERATING SEGMENTS

TABLE 251.    CHINA BIOLOGIC PRODUCTS, INC.: PRODUCT PORTFOLIO

TABLE 252.    CHINA BIOLOGIC PRODUCTS, INC.: KEY STRATERGY

TABLE 253.    CSL LIMITED: COMPANY SNAPSHOT

TABLE 254.    CSL LIMITED: OPERATING SEGMENTS

TABLE 255.    CSL LIMITED: PRODUCT PORTFOLIO

TABLE 256.    CSL LIMITED: KEY STRATERGY

TABLE 257.    GRIFOLS S.A.: COMPANY SNAPSHOT

TABLE 258.    GRIFOLS S.A.: OPERATING SEGMENTS

TABLE 259.    GRIFOLS S.A.: PRODUCT PORTFOLIO

TABLE 260.    GRIFOLS S.A.: KEY STRATERGY

TABLE 261.    KEDRION BIOPHARMA INC.: COMPANY SNAPSHOT

TABLE 262.    KEDRION BIOPHARMA INC.: OPERATING SEGMENTS

TABLE 263.    KEDRION BIOPHARMA INC.: PRODUCT PORTFOLIO

TABLE 264.    KEDRION BIOPHARMA INC.: KEY STRATERGY

TABLE 265.    LFB SA: COMPANY SNAPSHOT

TABLE 266.    LFB SA: OPERATING SEGMENTS

TABLE 267.    LFB SA: PRODUCT PORTFOLIO

TABLE 268.    LFB SA: KEY STRATERGY

TABLE 269.    OCTAPHARMA AG: COMPANY SNAPSHOT

TABLE 270.    OCTAPHARMA AG: OPERATING SEGMENTS

TABLE 271.    OCTAPHARMA AG: PRODUCT PORTFOLIO

TABLE 272.    OCTAPHARMA AG: KEY STRATERGY

TABLE 273.    SHIRE PLC.: COMPANY SNAPSHOT

TABLE 274.    SHIRE PLC.: OPERATING SEGMENTS

TABLE 275.    SHIRE PLC.: PRODUCT PORTFOLIO

TABLE 276.    SHIRE PLC.: KEY STRATERGY

 

 

LIST OF FIGURES

FIGURE 1.       Global  Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 2.       Hypogammaglobulinemia Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 3.       North America Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 4.       Europe Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 5.       Asia-Pacific Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 6.       Rest of World Hypogammaglobulinemia Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 7.       Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 8.       North America Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 9.       Europe Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 10.     Asia-Pacific Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 11.     Rest of World Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 12.     Primary Immunodeficiency Diseases Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 13.     North America Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 14.     Europe Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 15.     Asia-Pacific Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 16.     Rest of World Primary Immunodeficiency Diseases Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 17.     Myasthenia Gravis Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 18.     North America Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 19.     Europe Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 20.     Asia-Pacific Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 21.     Rest of World Myasthenia Gravis Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 22.     Multifocal Motor Neuropathy Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 23.     North America Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 24.     Europe Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 25.     Asia-Pacific Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 26.     Rest of World Multifocal Motor Neuropathy Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 27.     Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 28.     North America Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 29.     Europe Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 30.     Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 31.     Rest of World Idiopathic Thrombocytopenic Purpura (ITP) Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 32.     Inflammatory Myopathies Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 33.     North America Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 34.     Europe Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 35.     Asia-Pacific Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 36.     Rest of World Inflammatory Myopathies Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 37.     Specific Antibody Deficiency Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 38.     North America Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 39.     Europe Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 40.     Asia-Pacific Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 41.     Rest of World Specific Antibody Deficiency Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 42.     Guillain-Barre Syndrome Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 43.     North America Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 44.     Europe Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 45.     Asia-Pacific Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 46.     Rest of World Guillain-Barre Syndrome Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 47.     Other Application Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 48.     North America Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 49.     Europe Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 50.     Asia-Pacific Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 51.     Rest of World Other Application Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 52.     Global  Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 53.     IGG Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 54.     North America IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 55.     Europe IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 56.     Asia-Pacific IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 57.     Rest of World IGG Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 58.     IGA Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 59.     North America IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 60.     Europe IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 61.     Asia-Pacific IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 62.     Rest of World IGA Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 63.     IGM Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 64.     North America IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 65.     Europe IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 66.     Asia-Pacific IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 67.     Rest of World IGM Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 68.     IGE Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 69.     North America IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 70.     Europe IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 71.     Asia-Pacific IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 72.     Rest of World IGE Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 73.     IGD Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 74.     North America IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 75.     Europe IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 76.     Asia-Pacific IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 77.     Rest of World IGD Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 78.     Global  Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 79.     Global Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 80.     5% concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 81.     North America 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 82.     Europe 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 83.     Asia-Pacific 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 84.     Rest of World 5% concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 85.     10% Concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 86.     North America 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 87.     Europe 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 88.     Asia-Pacific 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 89.     Rest of World 10% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 90.     Other Concentrations Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 91.     North America Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 92.     Europe Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 93.     Asia-Pacific Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 94.     Rest of World Other Concentrations Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 95.     Intravenous Mode of Delivery Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 96.     North America Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 97.     Europe Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 98.     Asia-Pacific Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 99.     Rest of World Intravenous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 100.  Global Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 101.  16.5% Concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 102.  North America 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 103.  Europe 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 104.  Asia-Pacific 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 105.  Rest of World 16.5% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 106.  20% Concentration Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 107.  North America 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 108.  Europe 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 109.  Asia-Pacific 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 110.  Rest of World 20% Concentration Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 111.  Other Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 112.  North America Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 113.  Europe Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 114.  Asia-Pacific Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 115.  Rest of World Other Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 116.  Subcutaneous Mode of Delivery Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 117.  North America Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 118.  Europe Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 119.  Asia-Pacific Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 120.  Rest of World Subcutaneous Mode of Delivery Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 121.  Global  Immunoglobulin Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 122.  North America Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 123.  North America Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 124.  North America Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 125.  North America  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 126.  North America  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 127.  U.S. Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 128.  U.S. Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 129.  U.S. Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 130.  U.S. Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 131.  U.S. Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 132.  Canada Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 133.  Canada Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 134.  Canada Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 135.  Canada Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 136.  Canada Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 137.  Mexico Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 138.  Mexico Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 139.  Mexico Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 140.  Mexico Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 141.  Mexico Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 142.  Europe Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 143.  Europe Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 144.  Europe Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 145.  Europe  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 146.  Europe  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 147.  Germany Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 148.  Germany Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 149.  Germany Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 150.  Germany Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 151.  Germany Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 152.  UK Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 153.  UK Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 154.  UK Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 155.  UK Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 156.  UK Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 157.  France Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 158.  France Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 159.  France Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 160.  France Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 161.  France Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 162.  Italy Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 163.  Italy Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 164.  Italy Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 165.  Italy Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 166.  Italy Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 167.  Austria Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 168.  Austria Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 169.  Austria Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 170.  Austria Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 171.  Austria Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 172.  Russia Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 173.  Russia Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 174.  Russia Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 175.  Russia Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 176.  Russia Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 177.  Rest of Europe Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 178.  Rest of Europe Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 179.  Rest of Europe Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 180.  Rest of Europe Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 181.  Rest of Europe Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 182.  Asia-Pacific Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 183.  Asia-Pacific Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 184.  Asia-Pacific Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 185.  Asia-Pacific  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 186.  Asia-Pacific  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 187.  China Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 188.  China Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 189.  China Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 190.  China Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 191.  China Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 192.  India Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 193.  India Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 194.  India Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 195.  India Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 196.  India Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 197.  Japan Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 198.  Japan Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 199.  Japan Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 200.  Japan Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 201.  Japan Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 202.  Australia Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 203.  Australia Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 204.  Australia Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 205.  Australia Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 206.  Australia Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 207.  Rest of Asia-Pacific Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 208.  Rest of Asia-Pacific Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 209.  Rest of Asia-Pacific Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 210.  Rest of Asia-Pacific Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 211.  Rest of Asia-Pacific Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 212.  Rest of World Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 213.  Rest of World Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 214.  Rest of World Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 215.  Rest of World  Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 216.  Rest of World  Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 217.  Brazil Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 218.  Brazil Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 219.  Brazil Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 220.  Brazil Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 221.  Brazil Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 222.  Saudi Arabia Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 223.  Saudi Arabia Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 224.  Saudi Arabia Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 225.  Saudi Arabia Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 226.  Saudi Arabia Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 227.  Argentina Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 228.  Argentina Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 229.  Argentina Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 230.  Argentina Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 231.  Argentina Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 232.  Remaining Countries Immunoglobulin Market Value, By Application, 2019-2030, MILLION USD/VOLUME

FIGURE 233.  Remaining Countries Immunoglobulin Market Value, By Product, 2019-2030, MILLION USD/VOLUME

FIGURE 234.  Remaining Countries Immunoglobulin Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 235.  Remaining Countries Intravenous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 236.  Remaining Countries Subcutaneous Mode of Delivery Market Value, By Mode of Delivery, 2019-2030, MILLION USD/VOLUME

FIGURE 237.  BAXTER INTERNATIONAL INC.: NET SALES,2017-2019

FIGURE 238.  BAYER AG: NET SALES,2017-2019

FIGURE 239.  BIOTEST AG: NET SALES,2017-2019

FIGURE 240.  CHINA BIOLOGIC PRODUCTS, INC.: NET SALES,2017-2019

FIGURE 241.  CSL LIMITED: NET SALES,2017-2019

FIGURE 242.  GRIFOLS S.A.: NET SALES,2017-2019

FIGURE 243.  KEDRION BIOPHARMA INC.: NET SALES,2017-2019

FIGURE 244.  LFB SA: NET SALES,2017-2019

FIGURE 245.  OCTAPHARMA AG: NET SALES,2017-2019

FIGURE 246.  SHIRE PLC.: NET SALES,2017-2019

KEY PLAYERS:

  • CSL Ltd.
  • Baxter international Inc.
  • Octapharma AG
  • Grifols S.A
  • LFB group
  • Kedrion Biopharma Inc.
  • China Biologics Products, Inc.
  • Biotest AG
  • Shire PLC (Baxalta)
  • Bayer AG

Frequently Asked Questions
What will be the worth of global Immunoglobulin market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Immunoglobulin market business is expected to hit at $20.23 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Immunoglobulin Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Immunoglobulin industry?

CSL Ltd., Baxter international Inc., Octapharma AG, Grifols S.A, LFB SA, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Shire (Baxalta), and Bayer Healthcare

What are the market segmentations and scope of the study?

The global Immunoglobulin market share analysis is based on product, application, mode of delivery and region.

How big is the Immunoglobulin market?

Currently (in 2019), the market value stands at USD 11.23 billion and it is anticipated to reach USD 20.23 billion by 2030.